POSITRON CORP (POSC) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US7373976049

Price
1.70 USD
Market cap
55.84 m USD
P/E (2025)
–
P/S (2025)
121.01
Dividend yield
0.00 %
Net margin
-2,297.83 %
Return on equity (ROE)
-734.40 %
Return on assets (ROA)
-265.11 %

POSITRON CORP financials

Fiscal year20242025
Revenue587,500.00 USD461,452.00 USD
Gross profit-341,984.00 USD-2.11 m USD
Operating income-2.21 m USD-10.50 m USD
EBIT-2.24 m USD-10.48 m USD
Net income-2.38 m USD-10.60 m USD
Diluted EPS – continuing operations-0.09 USD-0.34 USD

Full history since 1992, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About POSITRON CORP

Positron Corporation, a medical technology company, co-develops, manufactures, and sells positron emission tomography and PET-computed tomography imaging systems in the United States. The company offers Attrius PET and NeuSight PET-CT 64-slice used in non-invasive diagnosis and evaluation of coronary artery disease and supports various molecular imaging applications, including cardiology, oncology, and neurology. It also provides clinical and technical support services, such as physician interpretation training, nurse and technologist training, billing and prior-authorization assistance, physician over-read services, 24/7 clinical and technical support, priority response with after-hours service availability, equipment uptime guarantees and software upgrades, and remote system diagnostics and maintenance capabilities. The company sells its products through internal sales and marketing team. It serves healthcare providers, imaging centers, hospitals, and cardiology practices. The company was incorporated in 1983 and is headquartered in North Tonawanda, New York.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.